Clover Corporation Limited
Research Clover Corporation Limited (CLV.AX) on Bullrun: market cap AUD 171.17M, P/E 17.1, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCLV.AX
- ExchangeAU
- CountryAustralia
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyAUD
- Market capAUD 171.17M
- P/E17.1
- Dividend yield2.0%
- Financial periodFY2025
- RevenueAUD 86.00M
- Revenue growth38.3%
- Net incomeAUD 7.02M
- Free cash flowAUD 6.95M
- Gross margin30.4%
Valuation Snapshot
latest market cap is AUD 171.17M; P/E is 17.1; dividend yield is 2.0%.
Peer valuation comparison
Latest P/E is 17.08x versus a Consumer Defensive sector median of 17.14x.
Latest dividend yield is 1.95% versus a Consumer Defensive sector median of 2.93% (33.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 86.00M | AUD 7.02M | AUD 6.95M | 30.4% | 0.04 | AUD 8.68M | AUD 2.42M | AUD 72.23M |
| FY2024 | AUD 62.21M | AUD 1.52M | AUD 6.13M | 27.1% | 0.01 | AUD 12.26M | AUD 10.39M | AUD 67.07M |
| FY2023 | AUD 79.88M | AUD 6.21M | AUD 5.10M | 29.7% | 0.04 | AUD 9.44M | AUD 11.71M | AUD 67.15M |
| FY2022 | AUD 70.66M | AUD 7.13M | AUD 4.98M | 30.5% | 0.04 | AUD 10.11M | AUD 12.08M | AUD 63.04M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 171.17M | 17.1 | 2.4% | 0.03 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.03 AUD, yield 2.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.02 AUD |
| FY2024 | 0.01 AUD |
| FY2023 | 0.02 AUD |
| FY2022 | 0.02 AUD |
About Clover Corporation Limited
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Clover Corporation Limited's market cap?
Clover Corporation Limited's market capitalization is AUD 171.17M.
What is Clover Corporation Limited's P/E ratio?
Clover Corporation Limited's price-to-earnings (P/E) ratio is 17.1.
Does Clover Corporation Limited pay a dividend?
Clover Corporation Limited has a dividend yield of 2.0%.
What does Clover Corporation Limited do?
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form.